Regulation

California Sets New Standards for Mental Health Parity Act
Public Policy California Sets New Standards for Mental Health Parity Act

Faisal Zain is at the forefront of healthcare technology, leveraging his expertise in the innovation of medical devices for diagnostics and treatment. Today, he delves into California's new regulations poised to transform mental health and substance use disorder coverage. These regulations,

Texas Faces Health Care Strain With Federal Funding Cuts
Public Policy Texas Faces Health Care Strain With Federal Funding Cuts

In the wake of recent federal funding reductions tied to new tax and spending legislation, Texas's health care system is navigating significant challenges. With cuts projected to affect Medicaid funding by a staggering $1 trillion over the coming decade, the implications are profound. This

Top Medicaid Planning Law Firms Protecting Elderly Assets
Public Policy Top Medicaid Planning Law Firms Protecting Elderly Assets

The growing complexity of Medicaid planning introduces significant challenges for families safeguarding elderly assets. With long-term care costs soaring and an aging population in need of support, navigating Medicaid's intricate rules is crucial. This scenario is not merely an exercise in

Are Digital Supplements Risking Patient Safety for Clicks?
Technology Are Digital Supplements Risking Patient Safety for Clicks?

In today's rapidly evolving landscape of digital health, Faisal Zain stands out as a thought leader well-versed in the intricacies of medical technology. His expertise lies in the innovative manufacturing of medical devices, which are pivotal in diagnostics and treatment. With a keen eye on

Navigating CMS-HCC Model V28: Tech-Driven Compliance Strategies
Technology Navigating CMS-HCC Model V28: Tech-Driven Compliance Strategies

The healthcare sector is experiencing a paradigm shift, brought forth by the CMS-HCC Model V28's emphasis on clinical specificity. This shift isn't merely a regulatory update but a redefinition of how healthcare organizations approach risk adjustment, documentation, and coding processes.

Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers
Public Policy Biopharma Faces Regulatory Shift: FDA, Trials, and Mergers

The biopharmaceutical sector is currently experiencing a dynamic phase marked by regulatory reforms, technological growth, and strategic corporate actions. This environment presents both challenges and opportunities for industry players, prompting adaptive strategies to thrive in an evolving

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later